<DOC>
	<DOCNO>NCT00143182</DOCNO>
	<brief_summary>Bipolar disorder characterize mood swing range high ( manic ) low ( depress ) state . Sometimes , symptoms depression mania present ( mixed episode ) . Asenapine investigational medication treatment manic mixed episode bipolar disorder . Patients complete 3 week trial ( A7601004 A7501005 ) continue treatment receive short term study : asenapine olanzapine ( medication already approve treatment bipolar mania ) 9 additional week . The short term study ( A7501004 A7501005 ) unblinded 9 week extension study unblinded . Patients treat placebo 3 week short term study cross treat Asenapine 9 week extension study . Patients complete 9 week extension study eligible continue another extension ( A7501007 ) study additional 40 week .</brief_summary>
	<brief_title>9 Week Extension Study Asenapine Olanzapine Treatment Mania ( P07007 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Have complete asenapine 3week study treatment acute manic mix episode major protocol violation.in short term study ( A7501004 A7501005 ) complete . Patients unstable medical condition clinically significant laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>